Every couple of years we ask our readers to let Great NonProfits know if we are doing a good job for you. And it’s that time again. … READ MORE …
Filed under: About Us | Tagged: Great NonProfits, review | 5 Comments »
Every couple of years we ask our readers to let Great NonProfits know if we are doing a good job for you. And it’s that time again. … READ MORE …
Filed under: About Us | Tagged: Great NonProfits, review | 5 Comments »
The American Society of Clinical Oncology (ASCO) and the College of Pathologists (CAP) have just issued a joint review of available information on clinical use of “liquid biopsies” to assess circulating levels of tumor DNA (ctDNA). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, circulating, ctDNA, DNA, liquid, review, test, tumor | 2 Comments »
The Intergroupe Coopérateur Francophone de Recherche en Onco-urologie (ICFuro) has just published a review of the available evidence on the clinical validity and utility of six prognostic biomarkers available for the assessment of prostate cancer-related risk. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: 4Kscore, Decipher, GPS, MiPS, Oncotype, phi, prognosis, PROLARIS, review, test | 4 Comments »
A new review article has just been published in the journal Critical Reviews in Hematology Oncology. It is probably a current “must read” for support group leaders and for any patients who are interested in the idea of using immunotherapy as a treatment for progressive and advanced forms of prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: immunotherapy, review | Leave a comment »
Recently posted on the UroToday web site are summaries of four “state-of-the-art” lectures on prostate cancer and its management presented a couple of weeks ago at the annual meeting of the European Association of Urology is London. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: hereditary, mCRPC, mpMRI, review, state-of-the-art | 10 Comments »
Various forms of focal therapy are now being used by some physicians to treat selected patients with well-identified, usually relatively small, “dominant” or “index” tumors that are confined to highly defined areas of the prostate. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal, pathology, patient. selection, review, therapy | 4 Comments »
A new review article has provided a detailed update on the current state of knowledge about the use of sipuleucel-T (Provenge®) in the treatment of advanced forms of prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: Provenge, review, sipuleucel-T, update | Leave a comment »
At least some of our readers will be interested in knowing about a series of straightforward, clinical review articles on various aspects of prostate cancer diagnosis and management that have just started to be published on line in a new journal called Everyday Urology – Oncology Insights. … READ MORE …
Filed under: Uncategorized | Tagged: article, review, series | 3 Comments »
A recent article in Expert Review of Anticancer Therapy has assessed the effectiveness and safety of focal cryotherapy in the first- and second-line treatment of localized prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cryosurgery, cryotherapy, focal, outcomes, review | 3 Comments »
Researchers from City of Hope in Los Angeles have conducted an expert, systematic review of the published literature on the use of robot-assisted, laparoscopic radical prostatectomy (RALP) in the management of high-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", laparoscopic, localized, outcome, prostatectomy, RALP, review, robot-assisted | 2 Comments »
The full text of a recent review on the use of LHRH receptor agonists (e.g., leuprolide acetate, goserelin acetate) asnd LHRH receptor antagonists (e.g., degarelix) has recently been published by Shore et al. in Prostate Cancer and Prostatic Diseases. The full text of the article is also available on line on the Medscape Oncology web site.
Filed under: Management, Treatment | Tagged: agonist, antagonist, LHRH, receptor, review | 3 Comments »
In another article in European Urology, Dall’Era et al. have provided a thorough review of published outcome data from the seven largest known series of patients being managed under active surveillance (AS). Unfortunately the full text of this article is not available on line. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, AS, indolent, review | Leave a comment »
Here is a link to a recent 20-minute video-discussion on the Medscape web site between an number of European experts on evolutions in the management of castration-resistant (and earlier forms of) prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: advanced, castration-resistant, mCRPC, review, video | Leave a comment »